{"title":"Lumbar-peritoneal shunt-associated meningitis and peritoneal abscess due to Corynebacterium striatum: A case report and literature review","authors":"Akiho Maeda , Koji Hayashi , Rina Izumi , Yusuke Tsujigiwa , Yuka Nakaya , Yoshitomo Fukuoka , Kohei Ueda , Norichika Hashimoto","doi":"10.1016/j.jiac.2025.102895","DOIUrl":null,"url":null,"abstract":"<div><div>We describe the first case of both a peritoneal abscess and a lumbar-peritoneal (LP) shunt infection related to <em>Corynebacterium striatum</em> (<em>C. striatum</em>). An 85-year-old Japanese male with a history of diabetes, hyperlipidemia, and a pulmonary vein isolation procedure for atrial fibrillation presented with urinary incontinence, gait disturbance, and cognitive decline. He was diagnosed with normal-pressure hydrocephalus (NPH) and underwent LP shunt surgery. Postoperatively, he developed pneumonia followed by an intra-abdominal abscess and bacterial meningitis. <em>C. striatum</em> was isolated from both cerebrospinal fluid (CSF) and intraperitoneal abscess. Despite antibiotic treatment including vancomycin, he developed septic shock and ultimately resulted in his death.</div><div>The LP shunt likely facilitated the entry of <em>C. striatum</em> into the CSF, resulting in meningitis and subsequent abscess formation. Despite appropriate antibiotic treatment including vancomycin, <em>C. striatum</em> infections can be resistant and lead to severe outcomes. This case highlights a new complication associated with <em>C. striatum</em>: bacterial meningitis and intraperitoneal abscesses via an LP shunt, expanding its clinical spectrum.</div></div>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":"32 1","pages":"Article 102895"},"PeriodicalIF":1.7000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection and Chemotherapy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1341321X25002934","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/12/12 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
We describe the first case of both a peritoneal abscess and a lumbar-peritoneal (LP) shunt infection related to Corynebacterium striatum (C. striatum). An 85-year-old Japanese male with a history of diabetes, hyperlipidemia, and a pulmonary vein isolation procedure for atrial fibrillation presented with urinary incontinence, gait disturbance, and cognitive decline. He was diagnosed with normal-pressure hydrocephalus (NPH) and underwent LP shunt surgery. Postoperatively, he developed pneumonia followed by an intra-abdominal abscess and bacterial meningitis. C. striatum was isolated from both cerebrospinal fluid (CSF) and intraperitoneal abscess. Despite antibiotic treatment including vancomycin, he developed septic shock and ultimately resulted in his death.
The LP shunt likely facilitated the entry of C. striatum into the CSF, resulting in meningitis and subsequent abscess formation. Despite appropriate antibiotic treatment including vancomycin, C. striatum infections can be resistant and lead to severe outcomes. This case highlights a new complication associated with C. striatum: bacterial meningitis and intraperitoneal abscesses via an LP shunt, expanding its clinical spectrum.
期刊介绍:
The Journal of Infection and Chemotherapy (JIC) — official journal of the Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases — welcomes original papers, laboratory or clinical, as well as case reports, notes, committee reports, surveillance and guidelines from all parts of the world on all aspects of chemotherapy, covering the pathogenesis, diagnosis, treatment, and control of infection, including treatment with anticancer drugs. Experimental studies on animal models and pharmacokinetics, and reports on epidemiology and clinical trials are particularly welcome.